DeutschNewstral
Article
Mmarketwatch.com on 2017-08-31 23:28
Iovance shares jump on FDA cancer drug fast-track designation
Related news
- BBluebird Shares Jump as FDA Approves Cancer Therapybarrons.com
- MPuma Biotech shares jump on breast cancer study, FDA applicationmarketwatch.com
- MNovavax shares soar 20% premarket after company wins FDA fast-track designation for flu vaccinemarketwatch.com
Durham cancer drug developer sees shares pop 35% on FDA designationbizjournals.com- MCan-Fite Bio shares surge about 40% as liver drug gets FDA fast track designationmarketwatch.com
- MAlnylam shares jump on FDA approvalmarketwatch.com
- IGenprex up by 130% after receiving FDA fast track designationinvezz.com
- MProQR shares rises on FDA orphan drug designationmarketwatch.com
- MAquestive shares jump on FDA approvalmarketwatch.com
- Portland biotech company gains FDA Fast Track designationbizjournals.com
Cerecor has FDA fast track designation for rare disease drugthedailyrecord.com- MPuma Biotech stock surges on FDA cancer drug designationmarketwatch.com
- MGenprex's stock rallies on FDA fast-track designationmarketwatch.com
Eisai shares jump after FDA approves Alzheimer’s drug lecanemabThe Japan Times
Pacira Pharma shares jump after FDA drops drug restrictionwkrg.com- MAcadia shares rise on FDA dementia drug designationmarketwatch.com
- Novavax gets FDA fast track designation for flu vaccinethedailyrecord.com
- Sanaria's malaria vaccine wins coveted FDA fast track designationbizjournals.com
- MOxyContin maker Purdue Pharma says FDA has granted fast track designation to its emergency opioid treatmentmarketwatch.com